Franz Villarroel-Espíndola

12PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Microbial geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 05, 2025
HERPUD1 mediates palmitic acid-induced UPR sustaining TNBC aggressiveness and is destabilized by CK2 pharmacological inhibition.

Laura Hernández-Torres, Viviana A Cavieres, Omar Cortés

|Aug 28, 2025
SALL2-Mediated Suppression of WNT Signaling Through Transcriptional Control of AXIN2 in Colorectal Cancer Cells.

Aracelly Quiroz, Emilia Escalona, Carlos Farkas

|May 14, 2025
Spatial Study of TLR4, TLR5 and TLR9 in Gastric Premalignant Lesions Before and After Helicobacter pylori Eradication.

Franz Villarroel-Espíndola, Leyla Jaupi, Joaquín Reyes

|Sep 28, 2024
Risk Factors for Ovarian Cancer in South America: A Literature Review.

Sergio Jara-Rosales, Roxana González-Stegmaier, Elena S Rotarou

|Feb 10, 2024
Historical and Molecular Perspectives on the Presence of Helicobacter pylori in Latin America: A Niche to Improve Gastric Cancer Risk Assessment.

Roxana González-Stegmaier, Patricia Aguila-Torres, Franz Villarroel-Espíndola

|Mar 11, 2023
Recombinant Domain of Flagellin Promotes In Vitro a Chemotactic Inflammatory Profile in Human Immune Cells Independently of a Dendritic Cell Phenotype.

Roxana González-Stegmaier, Adam Aguirre, Constanza Cárcamo

Pageof 2